Hemoglobin, C-reactive protein and ferritin in patients with oral carcinoma and their clinical significance - a prospective clinical study

Publication date: Available online 13 December 2017
Source:Journal of Cranio-Maxillofacial Surgery
Author(s): Sebastian Blatt, Holger Schön, Keyvan Sagheb, Peer W. Kämmerer, Bilal Al-Nawas, Eik Schiegnitz
AimFor oral squamous cell carcinoma (OSCC), biomarkers are much in need to predict prognosis and to overcome possible resistance mechanisms to adjuvant therapies. The aim of this study was to evaluate serum level of hemoglobin, C-reactive protein (CRP) and ferritin as possible liquid biopsy to predict survival, metastasis and tumor relapse of OSCC.Material and MethodsA prospective clinical study was conducted. Overall, serum levels of hemoglobin, CRP and ferritin in 82 OSCC patients and 63 controls were preoperatively investigated.ResultsPatients with an anemia showed a significant lower survival than patients with no anemia preoperative. Patients with T3/T4 cancer had significant lower hemoglobin values (p=0.002). CRP and ferritin were statistically overexpressed in late tumor stages T3/T4 (ferritin: p=0.045, CRP: p<0.05,) compared to control. Log Rank testing indicated a statistical correlation of upregulated ferritin levels with local tumor recurrence (p=0.012) and local lymph node metastasis (p=0.008).ConclusionPresented biomarker CRP, ferritin and hemoglobin may serve as a liquid biopsy for prediction of OSCC especially for larger tumor sizes, overall survival and tumor relapse and demand a more radical therapy approach.



http://ift.tt/2zbzi0f